Arief S. Gunawan, Donal P. McLornan, Bridget Wilkins, Katherine Waghorn, Yvette Hoade, Nicholas C. P. Cross and Claire N. Harrison (2017) “Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia”, Haematologica. Pavia, Italy, 102(6), pp. e238-e240. doi: 10.3324/haematol.2017.163790.